These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25758228)

  • 21. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II.
    Hart J; Hamilton EJ; Makepeace A; Davis WA; Latkovic E; Lim EM; Dyer JR; Davis TM
    J Diabetes Complications; 2015; 29(8):1092-7. PubMed ID: 26243688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antirheumatic drug use and the risk of acute myocardial infarction.
    Suissa S; Bernatsky S; Hudson M
    Arthritis Rheum; 2006 Aug; 55(4):531-6. PubMed ID: 16874796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality.
    Bouiller K; Gbaguidi-Haore H; Hocquet D; Cholley P; Bertrand X; Chirouze C
    Clin Microbiol Infect; 2016 May; 22(5):451-5. PubMed ID: 26851655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
    Zhang J; Xie F; Yun H; Chen L; Muntner P; Levitan EB; Safford MM; Kent ST; Osterman MT; Lewis JD; Saag K; Singh JA; Curtis JR
    Ann Rheum Dis; 2016 Oct; 75(10):1813-8. PubMed ID: 26792814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus infections in kidney transplantation: a matched case controlled study.
    Florescu DF; Qiu F; West SB; Richards S; Florescu MC; Stevens B; Hill L; Kalil AC
    Scand J Infect Dis; 2012 Jun; 44(6):427-32. PubMed ID: 22263696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer after exposure to disease modifying anti-rheumatic drugs.
    Bernatsky S; Clarke A; Suissa S
    Lung Cancer; 2008 Feb; 59(2):266-9. PubMed ID: 17673329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
    Bernatsky S; Hudson M; Suissa S
    Rheumatology (Oxford); 2007 Jul; 46(7):1157-60. PubMed ID: 17478469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.
    Bader MS
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1219-25. PubMed ID: 17080380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis.
    Mor A; Mitnick HJ; Greene JB; Azar N; Budnah R; Fetto J
    J Clin Rheumatol; 2006 Apr; 12(2):87-9. PubMed ID: 16601543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.
    Schimmel EK; Yazici Y
    Clin Exp Rheumatol; 2009; 27(3):446-51. PubMed ID: 19604437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of hospitalized infection in patients with rheumatoid arthritis.
    Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
    J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
    PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system.
    Rashid N; Lin AT; Aranda G; Lin KJ; Guerrero VN; Nadkarni A; Patel C
    J Med Econ; 2016 Jun; 19(6):568-75. PubMed ID: 26766553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.
    Curtis JR; Xie F; Yun H; Saag KG; Chen L; Delzell E
    Arthritis Rheumatol; 2015 Jun; 67(6):1456-64. PubMed ID: 25708920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
    Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
    JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
    Sato E; Tanaka E; Ochiai M; Shimizu Y; Kobayashi A; Shidara K; Hoshi D; Sugimoto N; Inoue E; Seto Y; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 May; 25(3):350-7. PubMed ID: 25619283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.